Select Medical (SEM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
4 Mar, 2026Executive summary
Annual meeting scheduled for April 23, 2026, to be held virtually at 11:00 am Eastern Time.
Proxy materials are available online, and shareholders are encouraged to review them before voting.
Voting can be done online or by requesting a paper copy of the proxy materials.
Voting matters and shareholder proposals
Election of Class II Directors is on the agenda.
Advisory vote on executive compensation for named executive officers.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Proposal to amend the certificate of incorporation to phase out the classified board structure.
Advisory vote on company proposal for shareholders to call a special meeting at a 25% ownership threshold.
Advisory vote on shareholder proposal for special meeting rights at a 10% ownership threshold, if presented.
Board recommends voting FOR all proposals except the 10% threshold for special meetings, which it recommends AGAINST.
Board of directors and corporate governance
Proposal to phase out the classified structure of the board, moving toward annual director elections.
Latest events from Select Medical
- Board seeks annual director elections, 25% special meeting threshold, and strong governance.SEM
Proxy Filing4 Mar 2026 - Consortium to acquire all outstanding shares for $16.50 cash per share; company to go private.SEM
Proxy Filing3 Mar 2026 - Board seeks approval for declassification, auditor ratification, and enhanced shareholder rights.SEM
Proxy Filing20 Feb 2026 - Q4 revenue up 6.4% with margin pressure and 2026 guidance; strategic review ongoing.SEM
Q4 202520 Feb 2026 - Q2 revenue up 5.1% to $1.76B, EBITDA rose, and debt reduced after Concentra IPO.SEM
Q2 20242 Feb 2026 - Q3 saw 6% revenue and EBITDA growth, leverage down to 3.38x after Concentra IPO and debt paydown.SEM
Q3 202417 Jan 2026 - Revenue and adjusted EBITDA rose in 2024, with strong segment growth and positive 2025 guidance.SEM
Q4 202423 Dec 2025 - Board recommends key governance changes, pay-for-performance, and strong risk oversight.SEM
Proxy Filing1 Dec 2025 - Key votes include director elections, governance reforms, and executive compensation approval.SEM
Proxy Filing1 Dec 2025